학술논문
Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042-2050
Document Type
Erratum
Author
Source
In: Diabetes care . (Diabetes care, 1 March 2019, 42(3):494)
Subject
Language
English
ISSN
19355548